📰 $CPRX Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies

$CPRX Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies